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ABSTRACT
A Continued Investigation of Craniofacial Growth 
in Infant Heart Transplant Recipients Receiving Cyclosporine
by
John Michael Comali
Master of Science in Orthodontics, Graduate Program in Orthodontics 
and Dentofacial Orthopedics 
Loma Linda University, June 2001 
R. David Rynearson, Chairperson
Cyclosporine is an effective immunosuppressive drug that has found widespread
application in organ transplantation. A couple of studies, however, have implicated
ucyclosporine as adversely affecting craniofacial growth in the pediatric population.
The purpose of this follow-up study was to continue to evaluate the possible untoward
effects of long-term use of cyclosporine on craniofacial growth in a group of infant heart
transplantation recipients by re-evaluating as many subjects as possible from the original
study and evaluating new subjects. A prospective group (N=29) of eighteen Caucasian
subjects (7 female and 11 male, ages 6-15 years) and eleven Hispanic subjects (3 female
and 8 male, ages 5-15 years) were evaluated in this study. Eleven of the 29 subjects (8
Caucasian and 3 Hispanic) participated in the original 1996 study and eighteen/29 were
new subjects bringing the combined sample size to 46 subjects (28 Caucasian and 18
Hispanic). None of the subjects had undergone orthodontic therapy. All subjects had
heart transplantations before six months of age and followed the Loma Linda University
International Pediatric Heart Transplantation immunosuppression protocol. The primary
immunosuppression agent was cyclosporine with azathioprine or methotrexate. Rescue
therapy for graft rejection consisted of glucocorticoid and/or polyclonal antibody therapy.
vm
None of the subjects received the immunosuppressant tacrolimus (FK506). Using lateral
cephalometric radiography, seven skeletal angular measurements (SNA, SNB, ANB,
GoGn-SN, NA-Pog, ArGoMe, Npog-AB) were examined and compared to contemporary
cephalometric norms. Hand/wrist radiographs were evaluated for bone age. Also,
longitudinal height, weight, and head circumference data was obtained and compared to
standard NCHS growth and development curves. Longitudinal subjects (returning 1996
study participants) were also evaluated for retrognathic craniofacial growth vector trends
via cephalometric superimpositions. Statistical analysis, and descriptive statistics were
used to summarize the data. Cephalometrically, 78% (14 of 18) of the new subjects,
showed minor deviations from mean normative values. Four new subjects (22%) did
exhibit cephalometric values indicative of individuals with a vertical growth pattern, but
this may not be any different than a random sample of non-medically compromised
subjects. Of the eleven longitudinal subjects evaluated, three exhibited a mandibular
growth pattern tending toward retrognathia. Analysis of the hand/wrist radiographs
showed all but three subjects to have normal bone age. Height, weight and head
circumference data revealed a wide range of growth percentiles for the entire group and
suggested a tendency toward delayed statural development. The findings of this
longitudinal study concur with those of the 1996 pilot study and indicated that skeletal
growth of the craniofacial complex and axial skeletal growth generally did not differ
more than two standard deviations from normative data. The role of cyclosporine and its
possible adverse effects on craniofacial growth and development needs to be evaluated
via additional longitudinal data compilation and analysis over a greater length of time.
ix
I. INTRODUCTION
Pediatric heart transplantation is now entering its second decade of clinical
experience. The age range of children receiving transplants varies from neonates to
teenagers. The number of transplantations continues to increase because of broadening
indications for heart transplantation and because of the success of this treatment modality
in patients of this age range. More and more individuals are directed toward
transplantation rather than autogenous surgical reparative procedures which have a less 
favorable outcome.3,4
Indications for transplantation include hypoplastic left heart syndrome, idiopathic
cardiomyopathy, congenital heart disease, complex structural anomalies, endocardial
fibroelastosis, and tumors.5,6 Of the above, hypoplastic left heart syndrome (known as
HLHS or aortic arch hypoplasia), is by far the most common cyanotic congenital heart
disease. Prior to the mid-1980’s, palliative open-heart surgical operations brought about
only temporary benefit with an inexorably progressive and fatal prognosis without 
transplant.
The introduction of cyclosporine in the early 1980’s to control graft rejection in
renal allografting brought about a surge of activity in the field of heart transplantation.
including pediatrics. Carefiil selection of pediatric transplant recipients has resulted in
operative and short-term patient survival comparable to that achieved in adult transplant
8programs.
A 1991 international survey of cardiac transplantation in children provided data
from 381 transplantations in 362 patients (some patients requiring more than one
1
transplantation) from 32 centers in the United States and ten international centers.
Actuarial survival rates were 85% at 1 month, 72% at 1 year, 64% at 3 years, and 60% at 
5 years.4 More recent data from individual heart transplant programs such as Loma
Linda University Medical Center and Stanford University Medical Center report 5-year
actuarial survival rates at 80% and 69% respectively. Unfortunately, 10% to 25% of the
infants listed for transplantation annually die before receiving a donor heart.5,6
The leading causes of post transplant deaths are due to ventricular dysfunction.
graft rejection, infection, pulmonary hypertension, coronary artery disease, 
lymphoproliferative disease, and cytomegalovirus in the immune compromised host.4,9
Improved survival rates and decreased graft rejection are attributed, in part, to
improved posttransplant immunomodulation. The two most common
immunosuppression regimens are 1) triple-drug combinations of cyclosporine,
10-13azathioprine, and prednisone and 2) primary-drug-based with FK506 (tacrolimus).
Cyclosporine is an essential component of the antirejection drug protocol used in 
the long-term management of pediatric organ transplant recipients.14 This agent is a 
lipophylic cyclic polypeptide that produces calcium-dependent, specific, reversible
inhibition of interleukin-2 transcription by T helper lymphocytes. This results in reduced
production of several cytokines and inhibition of activation and /or maturation of various
cell types including those involved in cell-mediated immunity. Thus, cyclosporine is 
used as first line therapy in the prophylaxis and treatment of transplant rejection.15
Although the use of cyclosporine has led to significant graft survival, studies have
documented deleterious side effects including nephrotoxicity, hepatotoxicity, hirsutism.
2
gingival hyperplasia, hypertension, elevated blood urea nitrogen and creatinine levels and
6,16,17tremors.
Studies by Reznik et al1 linked cyclosporine with prednisone to changes in fecial
appearance and abnormal fecial bone growth in pediatric renal transplant recipients. The
initial non-cephalometric study by Reznik’s group reported that the fecial features of
eleven children became coarse. There was thickening of the nares, lips, ears, puffiness of
the cheeks, prominence of the supraorbital ridges, and mandibular prognathism. They
also reported that patients treated with non cyclosporine immunosuppressants did not 
show facial changes, thus implicating cyclosporine in their etiology.1 They felt that
changes in facial appearance in the cyclosporine treated renal transplant patients 
resembled those seen with phenytoin (anticonvulsant) therapy.18
A follow-up study by Reznik et al2 used cephalometric radiography to 
demonstrate a pattern of abnormal facial growth in eight of nine renal transplant
recipients receiving cyclosporine and prednisone. The comparative control group was
renal transplant patients treated with an immunosuppressive regimen of azathioprine and
prednisone. The abnormalities in the cyclosporine-treated patients included shortening of
posterior facial height and increased anterior facial height with a steep mandibular plane
angle, and shortening of the mandibular body and retrognathia (which is opposite of the 
finding of mandibular prognathism noted in her first study).1,2 Reznik’s cephalometric
measurements found that the ANB angle (sagital relationship of the maxilla to the
mandible, see Figure 1 and 2) of the cyclosporine group was larger than that of the
azathioprine control group indicating a relatively retrognathic mandible. They also found
a significant difference in the relationship of the cranial base to the inferior border of the
3
mandible, GoGn-SN see Figure 1 and 2, with the cyclosporine group having a larger
GoGn-SN than the control group, indicating a steep mandibular plane angle. Reznik et 
al1,2 concluded the clinical implication of these findings indicated a retrusive chin, a long
face vertically and a corresponding malocclusion featuring the lower teeth posterior to
where they should be in relation to the upper teeth due to an apparent retro gnathic 
mandible with a steep mandibular plane angle.2 Reznik’s findings raised important 
questions regarding possible dysmorphic craniofacial growth in transplant patients
receiving cyclosporine.





Figure 2. Cephalometric planes and angels.
The purpose of a study by Niles et al19 at the Loma Linda University School of
Dentistry was to initiate the formation of a longitudinal study to evaluate the effects of
long-term cyclosporine immunosuppression on craniofacial growth in the pediatric heart
transplant patient treated in the International Pediatric Heart Transplantation Program at
Loma Linda University Children’s Hospital (LLUCH). This pilot study intended to
gather initial growth data of pediatric transplant patients receiving cyclosporine
immunosuppression and compares this with normative growth study data derived from
non-medically compromised subjects.
The initial study group (N=28) consisted of 18 Caucasians of European ancestry
(9 female and 9 male, ages 4-10 years) and 10 of Hispanic descent (3 female and 7 male,
ages 4-10). None of the subjects had undergone orthodontic therapy and all had heart
transplants before six months of age at LLUCH. The primary immunosuppression agent
was cyclosporine, with azathioprine or methotrexate adjunctive therapy. Glucocorticoid
and/or polyclonal antibody were used for rescue therapy for graft rejection. The
immunosuppressant tacrolimus (FK506) was not used. Seven skeletal angular
measurements (SNA, SNB, ANB, GoGn-SN, NA-Pog, ArGoMe, Npog-AB, see Figure 2
and 3) were examined by lateral cephalometric radiography and compared to
contemporary growth standards. Hand/wrist radiographs were evaluated for bone age.
and longitudinal height, weight, and head circumference data was compared to
standardized growth and development curves. Cephalometrically, 86% (N=24) had
minor deviation from mean normative values. Four subjects (14%) exhibited
cephalometric measurements indicative of a vertical growth pattern. Hand/wrist
radiographs showed all but one subject to have normal bone age, while height, weight,
6
and head circumference data revealed smaller stature and weight for many of the subjects
with a wide range of growth percentiles and mean percentiles less than 50%. Also noted 
was a significant incidence of congenitally missing permanent teeth.19
Figure 3. Cephalometric planes and angles.
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The investigators19 concluded “skeletal growth of the craniofacial complex as
well as axial skeletal growth was not altered by the immunosuppressive regimen of
cyclosporine over the time period evaluated.”
The purpose of this thesis is to continue the longitudinal study designed by Niles 
et al19 to evaluate the possible untoward effects of a long-term regimen of cyclosporine
immunosuppression on the overall growth pattern and craniofacial growth of infant heart
transplant recipients. The specific aims of this continuing study were to:
Compare the new subjects individual and collective cephalometric data 
with normative data as performed in the initial study.
Compare the new subjects individual and collective bone age and 
chronological age via hand-wrist radiographs and a radiographic atlas as 
performed in the initial study.
Compare the new subjects individual and collective heights, weight and 
head circumference with NCHS percentiles as performed in the initial 
study.
Evaluate craniofacial growth of the longitudinal children continuing in this 
new study by comparing their cephalometric data from the initial study 
with their new data and by cephalometric superimposition to evaluate for 
any growth vector change.
Evaluate the new subjects for missing permanent teeth and for possible 
ankylosis of primary molars.
Evaluate for any possible untoward effects of long-term cyclosporine 









II. METHODS AND MATERIALS
A prospective group of twenty-nine pediatric heart transplantation patients
currently on maintenance cyclosporine based immunosuppression therapy were evaluated
in this study. The subjects were infant heart transplant recipients treated in the
International Pediatric Heart Transplantation Program at Loma Linda University
Children’s Hospital. Some of the subjects were continuing from the initial study while
some were new to the ongoing study. Inclusion criteria for this study was the same as for
the initial study: “Pediatric patients who required heart transplantation before six months
of age and who were four years of age or older at the beginning of the study.”
Consistent with the Niles et al19 study, children with known associated genetic problems,
hormonal deficiencies, major organ failures, and other related syndromes were excluded
from this evaluation in an effort to minimize confounding variables. The composition of
the study group was as follows: eighteen subjects were Caucasian of European ancestry
(11 male and 7 female, ages 5 years-7 months to 14 years-11 months) and eleven were of
Hispanic descent (8 male and 3 female, ages 5 years-8 months to 15 years-1 month).
Eight Caucasian subjects and three Hispanic subjects participated in the initial 1996 pilot
study and comprised the longitudinal portion of the current sample. Age groups were
determined by including in each age interval, radiographs taken six months before a birth
20month through five months after a birth month.
All patients followed the Loma Linda University International Pediatric Heart
Transplantation immunosuppression protocol with the primary post transplantation
immunosuppression agent being cyclosporine with decreasing doses of azathioprine or
9
methotrexate. Target radioimmunoassay (RIA) whole blood levels of cyclosporine were
maintained at therapeutic doses of 150-350 ng/dl. The use of adjunctive agents such as
polyclonal antibody therapy and/or pulse glucocorticoids was limited to severe or chronic
graft rejection. Once again, none of the patients received the immunosuppressive agent
tacrolimus (FK506).
Radiographic and photographic data was gathered on each patient in an effort to
conduct a craniofacial growth analysis. Each child had a lateral cephalograph, panoramic
radiograph, hand/wrist radiograph, and a standard orthodontic photographic series
(frontal, frontal smiling, profile and five intra-oral) taken. The hand-wrist radiograph
was a standard right hand carpal index taken with the hand and wrist of each subject in
full contact with the film cassette with no focusing grid in place. This produced a less
than measurable amount of magnification. The panoramic radiograph was taken with a
thyroid shield in place. The lateral cephalograph was obtained by the Broadbent
cephalometric technique which positioned the subject’s head in a cephalostat oriented to
21the Frankfurt Horizontal Plane. An anode-to-object distance of five feet was used. The
object-to-film distance was standardized at 13 cm to produce a consistent 9%
enlargement factor. Standard anatomic landmarks from each cephalograph were
identified and traced on standard 0.003-inch acetate matte tracing paper by the principal
investigator. Each landmark location was reviewed by at least one other investigator
prior to computer digitization. The cephalometric analysis was completed using the
Quick Ceph Image Pro (San Diego, CA) software program. The following landmarks
were identified on each lateral cephalograph: sella turcica (S), nasion (N), point A (A),
10
point B (B), pogonion (Pog), gnathion (Gn), gonion (Go), menton (Me), and articulare
19,20,22(Ar) (Figure 1). The definitions for these landmarks have been widely published.
Once the anatomical landmarks were identified, the following skeletal angular
parameters were measured and tabulated for each subject: SNA, SNB, ANB, GoGn-Sn
Angle of Convexity (NAPog) and Gonial angle (ArGoMe), A-B Plane (Npog-AB). (See
19,23-25 Descriptive statistics were used to compare the acquiredFigures 2 and 3.)
cephalometric data with normative non-medically compromised subject data. Caucasian
subjects of European ancestry were analyzed against the normative standards from the
19,20Michigan growth study (Table 1). This comparative database was compiled in Ann
Arbor and involved a typically non-medically compromised group of normal growing
children including those with mild and moderate malocclusions. Subjects of Hispanic
decent were analyzed against cross-sectional data obtained through research at the
University of Texas at Houston. (See Table 1.) All children of the UT Houston group 
had normal profiles and Angle Class I occlusions.19,26,27 This sample, although not
typical of a random population, represented an adequate database for comparison and is
one of the largest Hispanic databases available.
Each hand/wrist radiograph was compared to Greulich and Pyle’s Radiographic
Atlas of Skeletal Development of the Hand and Wrist and was analyzed for axial skeletal
growth deviations by a pediatric radiologist from the Loma Linda University Medical
Center Children’s Hospital.
11














76.0 3.0 8 1076.2 0
5.4 2.5 11 55.3 2
4.7 8 739.5 40.0 3
5.2 13 411.3 11.3 1
130.3 4.5 8 7133.9 3
-6.7 3.4 13 5-6.3 0





StdDev +1 SD +2 SD >or<2SDMeasurements
SNA
SNB
3.1 8 1 1
76.4 3.0 6 478.4 0
5.8 1.7 4 54.6 1ANB 
GoGn-SN 
Angle of Convexity 
Gonial Angle 
A-B Plane Angle
10 037.9 36.5 5.7 0
12.2 6.6 8 110.9 1
128.9 6.3 7 2131.7 1
6.4 8 2-4.6 -1.3 0
Table 1. Cephalometric norms.
Each of the transplanted subjects height and weight from age three until the time
of the study was plotted using the NCHS (National Center for Health Statistics)
percentile ranking graph system. Consistent with the 1996 study, the most recent data
which correlated with each subjects chronologic age was plotted. Head circumference
measurements were recorded at about 36 months of age. Data recorded for the subjects
was plotted and analyzed against standard pre-pubescent growth and development 
statistics percentiles data from the National Center for Health Statistics.
Review of medical records also provided target radioimmunoassay (RIA) whole
blood levels of Cyclosporine and glucocorticoid (Solumedrol and/or Prednisone rescue
therapy for graft rejection) exposure of each subject. This information was compared to
the subject’s growth data to see if any significant correlation or trend existed between
12
dosage levels of cyclosporine, glucocorticoid exposure, and abnormal or dysmorphic
patterns of growth.
Cephalometric superimposition of lateral cephalographs was performed via the
American Board of Orthodontics format: “a registration on sella with the best fit on the
anterior cranial base bony structures Planum Spheniodium, Cribiform Plate and Greater
Wing of the Sphenoid.”29 This format was used to identify a possible change in the
growth pattern of the maxilla and mandible in relation to the cranial base.
Subjective, photographic and panoramic radiographic findings were noted. Areas
of concern were facial appearance abnormalities, presence of hypertrichosis, gingival




The cephalometric skeletal parameter measurements for subjects of both the 1996
and 2001 Caucasian and Hispanic transplantation groups are recorded in Figures 4 and 5.
Tables 2 and 3 show the Caucasian and Hispanic descriptive statistical data and mean
normative values for each cephalometric parameter recorded in the 2001 study. The two
series of seven graphs (Figures 4 and 5) compare each group’s seven individual
cephalometric parameters with normative data. For each angular measurement graph, the
patients individual data is plotted vertically as dots with their collective mean and one
standard deviation from their mean represented on an adjacent vertical line. For the
purpose of comparing the subjects individual and collective data with normative data,
each angular measurement graph shows the normative mean, and first and second
standard deviations from the normative mean on a vertical line with horizontal dashed
lines extending from both the first and second standard deviation points. This graph
system allows for a comparison of the means of each group’s seven angular
measurements against each group’s normative means and for a comparison of the
individual data plotted, to the normative first and second standard deviation dashed lines.
This graph system also allows for a comparison of returning longitudinal subjects
individual cephalometric data recorded in 1996 versus 2001 (Table 4) so that we might
detect trends in their pattern of craniofacial development over the last five years.
Figure 4 indicates that the difference between the Caucasian mean norms and the
1996 recorded mean values ranged from 0.0 to 0.5 degrees for six of the seven angular
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Legend
CN = Caucasian Norms: mean with 1st and 2nd SD 
limits
CT = Caucasian Transplant: mean and 1st SD 
ICTD = Individual Caucasian Transplant Data 
REC# = Subject Record Number
Figure 4. Comparison of the 1996 and 2001 cephalometric data with normative data (Caucasian).
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Figure 4. Continued.
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Figure 5. Comparison of the 1996 and 2001 cephalometric data with normative data (Hispanic).
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37.1 10.0 130 -10.0
4 76.7 28.9 4.0 120 -8.5
6 85.5 42.2 13.0 138 -7.0
8 89.1 37.0 20.0 124 -11.0
14 83.6 35.2 -2.0 128 -2.5
15 79.2 40.8 15.0 124 -11.5
16 88.7 32.0 8.5 125 -8.5
17 82.6 33.0 6.0 124 -5.0
29 83.1 39.0 16.0 126 -8.5
30 88.4 36.3 18.5 133 -10.0
31 73.4 50.9 9.0 137 -5.0
32 82.7 42.7 8.0 139 -4.5
33 84.2 46.7 21.5 135 -11.5
34 80.4 50.4 15.0 133 -10.0
35 78.6 38.9 12.0 123 -9.0
36 83.2 78.1 5.1 36.7 10.0 117 -8.5
37 32.884.9 80.6 4.3
76.5 7.5
9.0 126 -6.0



















6.2 6.0 7.2 2.6
26.8 35.638.4 51.8 6.7
1.0 1.5 1.4 1.7 0.6
4.9 15.8 51.0 5.6 -31.9
73.4 70.4 0.7 28.9 -2.0 117.0
143.0
-11.5
89.1 83.5 10.1 50.9 21.5 -2.5












0.4 -0.4 0.3 0.6
0.5 -0.8-0.4 0.2 -0.3
Table 2. Cyclosporine study - Caucasian sample - 2001.
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CYCLOSPORINE STUDY - HISPANIC SAMPLE 2001
Record Angle
Convx
Gonial AB Plane 
Angle Angle# SNA SNB ANB Go-Gn-SN
19 86.6 80.5 6.1 33.4 15.0 120 -7.5
21 86.4 84.3 2.1 36.3 5.5 137 -3.0
24 81.1 77.9 3.2 39.0 7.0 134 -4.0
85.439 90.5 5.1 25.9 11.0 116 -7.0
40 83.1 71.4 11.7 47.4 26.0 137 -13.5
41 85.9 77.9 8.0 38.5 17.5 135 -11.0
42 84.1 74.7 9.5 47.9 23.0 142 -12.0
43 88.1 77.9 10.2 46.4 21.0 135 -10.0
44 79.6 7.272.3 43.4 16.5 130 -8.0
45 79.3 74.7 4.6 41.1 12.0 126 -6.0














84.1 77.8 6.2 40.3 14.2 131.7 -7.6
3.8 4.5 3.5 6.7 7.6 8.0 3.7
14.3 19.9 11.9 44.4 57.1 63.6 14.0
1.01.1 1.3 2.0 2.3 2.4 1.1
4.5 5.7 55.3 16.5 53.1 6.1 -49.0
79.3 71.4 0.9 25.9 2.0 116.0
142.0
-13.5
90.5 85.4 11.7 47.9 26.0 -2.0
11.2 14.0 10.8 22.0 24.0 26.0 11.5




84.1 77.9 6.1 41.1 15.0 -7.5
#N/A #N/A77.9 #N/A #N/A #N/A
0.2 0.3 0.0 -0.9 -0.1 0.0-1.0
-1.1 -0.5 -1.0 0.8 -0.9 0.1 -1.0
Table 3. Cyclosporine study - Hispanic sample - 2001.
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CYCLOSPORINE STUDY - 1996/2001 LOGITUDINAL COMPARISION
Caucasian Sample
AB Plane AB Plane 
Angle Angle
Angle Angle Gonial Gonial 
Convx Convx Angle AngleRecord SNA SNA SNB SNB ANB ANB Go-Gn-SN Go-Gn-SN
# 96 01 96 01 96 01 9696 01 96 01 0196 01
3 85.8 84.0 80.1 77.7
80.8 76.7 71.1 73.1
80.3 85.5 72.6 79.5
79.0 89.1 71.6 79.9
82.1 83.6 79.4 82.9
84.0 79.2 81.1 72.0
78.6 88.7 77.2 83.5









-6.5 -10.05.7 6.4 37.4 37.1 12.4 128.410.0
4 9.7 46.9 28.9 139.1 -8.7 -8.53.7 20.6 4.0
6 7.8 -9.0 -7.06.0 43.9 42.2 18.8 138.413.0
8 7.4 9.2 43.4 130.8 -9.6 -11.037.0 14.7 20.0
14 2.7 0.7 128.6 -4.4 -2.535.0 35.2 4.0 -2.0
15 2.2 -3.17.2 34.2 40.8 4.0 15.0 135.2 -11.5
16 -8.51.4 5.2 41.2 32.0 130.6 -2.12.5 8.5
17 5.5 3.2 40.2 127.2 -8.1 -5.033.0 11.6 6.0
Sample
Mean 82.62 82.90 76.19 77.08
ro
5.43 5.84 39.53 129.17 -6.47 -8.0839.20 11.25 11.69 143.15
Hispanic Sample
Angle Angle Gonial Gonial 
Convx Convx Angle Angle
AB Plane AB Plane 
Angle AngleRecord SNA SNA SNB SNB ANB ANB Go-Gn-SN Go-Gn-SN
# 96 01 96 01 96 01 96 96 96 96 0101 01 01
19 85.1 86.6 76.4 80.5 8.6 6.1
21 82.2 86.4 77.0 84.3 5.2 2.1
24 79.2 81.1 76.2 77.9






39.6 36.3 -3.9 -3.0
3.1 3.2 36.4 39.0 -3.1 -4.0
Sample
Mean 83.34 84.5 78.44 77.83 4.90 6.24 37.67 40.28 -4.95 -7.6411.37 14.23 131.77 131.73
Table 4. Cyclosporine study - 1996/2001 logitudinal comparison.
difference between the Caucasian mean norms and the 2001 recorded mean value ranged
from 0.4 to 1.6 degrees for the seven angular parameter measurements. Figure 5
indicates the difference between the mean norms and the 1996 recorded mean values for
the Hispanic group ranged from 0.8 degrees to 3.7 degrees. The difference between the
mean norms and the 2001 recorded mean values for the Hispanic group ranged from 0.4
to 3.8 degrees for six of the seven angular parameter measurements, with the seventh
angular parameter value, A-B Plane Angle, differing by 6.3 degrees. The majority of the
individual subjects in each group were within two standard deviations of the norm for
each measurement. These findings would suggest a relatively normal pattern of facial
growth for the majority of this sample. The cephalometric measurements with one or
more individuals greater than two standard deviations from the norm for the 2001
Caucasian sample were SNA (2), GoGn-SN(2) and Gonial Angle (1 steep angle, 1
shallow angle). The cephalometric measurements with one or more individuals greater
than 2 standard deviations from the norm for the 2001 Hispanic sample were SNA (1),
SNB (1), ANB (3 high, 1 low), Angle of Convexity (1), and Gonial Angle (1 steep angle.
1 shallow angle). However, of the new subjects evaluated (N=18), only one Caucasian
subject (#31) and three Hispanic subjects (#40, #42, #43) exhibited a pattern of growth
similar to those implicated in Reznik’s second investigation, that of a steep mandibular
plane angle and mandibular retrognathia based on a large ANB angle and an increased
GoGn-SN value. Data for the longitudinal subjects revealed only three subjects (#3, #4,
#15) with growth trends leaning towards retrognathia.
Figures 6 and 7 combine all first time (cumulative data base) cephalometric
skeletal angular parameter values for the 1996 and 2001 Caucasian and Hispanic
22
SNA (Degrees) SNB (Degrees) ANB (Degrees)
1595 95Caucasian 1996 and 2001 
Cumulative (N=28)
Caucasian 1996 and 2001 
Cumulative (N=28)
Caucasian 1996 and 2001 
Cumulative (N=28)90 90
10 I:85 85-T T
81.981 3 5.8 i:5.4I80 80 5I- ii76.176.075 75 i.
-------- 1> 0:
70 70
CN CT ICTD CN CT ICTD CN CT ICTD65 65
Angle of Convexity (Degrees)GoGn-SN (Degrees) Gonial Angle (Degrees)
55 30 150Caucasian 1996 and 2001 








CN CT ICTDCN CT ICTD CN CT ICTD-520 110
A-B Plane Angle (Degrees)
20
Caucasian 1996 and 2001 
Cumulative (N=28) Legend15
10 CN = Caucasian Norms: mean with 1st and 2nd SD 
limits
CT = Caucasian Transplant: mean and 1 st SD 
ICTD = Individual Caucasian Transplant Data 




i-5 f--6.7 -7.1 ----IT-10
-15
CN CT ICTD-20
Figure 6. Comparison of the 1996 and 2001 cumulative cephalometric data with 
normative data (Caucasian).
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SNA (Degrees) SNB (Degrees) ANB (Degrees)
1595 95Hispanic 1996 and 2001 
Cumulative (N=18) Hispanic 1996 and 2001 Cumulative (N=18)
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GoGn-SN (Degrees) Angle of Convexity (Degrees) Gonial Angle (Degrees)
55 30 150Hispanic 1996 and 2001








HN HT IHTDHN HT IHTD HN__HT IHTD-520 110
A-B Plane Angle (Degrees)
20
Hispanic 1996 and 2001 
Cumulative (N=18) Legend15
10 HN = Hispanic Norms: mean with 1st and 2nd SD limits 
HT = Hispanic Transplant: mean and 1st SD 
IHTD = Individual Hispanic Transplant Data 







Figure 7. Comparison of the 1996 and 2001 cumulative cephalometric data with 
normative data (Hispanic).
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transplantation groups. Measurements for the 2001 longitudinal subjects (returning
subjects who participated in both the 1996 and 2001 studies) have intentionally been left
out to more accurately compare the total cumulative sample data with normative data.
Tables 5 and 6 show the descriptive statistical data and mean normative values for each
cephalometric parameter recorded for the 1996 and 2001 cumulative Caucasian and
Hispanic subjects. Figure 6 indicates the difference between the Caucasian mean norms
and the cumulative recorded mean values ranged from 0.1 to 0.8 degrees for six of the
seven angular parameter measurements, with the Gonial Angle value differing by 2.8
degrees. Figure 7 indicates the difference between the mean norms and the cumulative
recorded mean values for the Hispanic group ranged from 0.1 degrees to 0.3 degrees for
six of the seven angular parameter measurements, with the seventh angular parameter, A-
B Plane Angle, differing by 6.3 degrees. Once again, the majority of the individual
subjects in each group were within two standard deviations of the norm for each
measurement, suggesting a relatively normal pattern of facial growth for the majority of
this sample.
Each subject’s chronologic age was compared with his or her skeletal or bone age
as determined via their hand/wrist radiograph using Gruelich and Pyle’s Radiographic
Atlas. Table 7 shows that 22 of the 29 subjects analyzed had a normal or advanced axial
skeletal bone age. Figure 8 plots the difference between each new individuals bone age
and chronologic age with the (0) dashed line representing coincidence of chronologic age
and bone age. This scatter plot shows that 11/18 subjects were within one standard
deviation and that 4/18 subjects (#37, #38, #40 decreased, #46 increased) were within
two standard deviations. Only 3/18 subjects (#31, #35, #42) showed a decreased bone
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CYCLOSPORINE STUDY - CAUCASIAN SAMPLE 
1996 (1-18) AND 2001 (29-38) - Cumulative
Record Angle Gonail 
Convx Angle
AB Plane 
Angle# SNA SNB ANB Go-Gn-SN
82.01 75.75 6.5 38.9 135.312.8 -8.0
2 78.3 74.8 3.5 28.5 6.4 127.8
128.4
-5.7
80.13 85.8 5.7 37.4 12.4 -6.5
4 80.8 71.1 917 46.9 20.6 139.1 -8.7









6 80.3 72.6 43.97.8 18.8 -9.0
4.07 76.7 72.6 48.4 8.9 -5.4
8 79.0 71.6 7.4 43.4 14.7 -9.6
9 86.4 80.4 6.0 14.443.2 -6.9
84.910 77.1 18.57.8 44.3 -5.4
11 84.3 81.0 3.4 36.9 7.9 -4.2
12 73.283.0 9.8 44.4 22.0 -10.6
13 80.9 5.975.1 33.9 10.7 130.3 -7.0
















15 84.0 81.8 2.2 34.2 4.0 -3.1
16 77.278.6 2.51.4 41.2 -2.1
17 79.2 73.6 40.25.5 11.6 -8.1
18 80.0 74.8 5.2 33.0 4.3 -9.3
29 75.983.1 7.2 39.0 16.0 -8.5
30 88.4 78.8 9.5 36.3 18.5 -10.0
31 70.473.4 3.0 50.9 9.0 -5.0
32 82.7 79.2 3.5 42.7 8.0 -4.5
84.233 74.1 10.1 46.7 21.5 -11.5
34 72.980.4 7.5 50.4 15.0 -10.0
35 78.6 72.9 38.9 12.05.7 -9.0
36 83.2 78.1 5.1 36.7 10.0 -8.5
37 84.9 80.6 4.3 32.8 9.0 -6.0














76.1 5.8 40.4 12.1 133.1 -7.1
3.2 3.4 2.4 5.7 5.6 7.1 2.6
6.010.4 11.3 32.3 31.5 50.2 6.5
0.6 0.50.6 1.1 1.1 1.3 0.5
3.9 4.4 42.4 14.1 46.4 5.3 -36.2
73.4 70.4 1.4 28.5 2.5 117.0
143.5
-11.5
81.888.4 10.1 22/050.9 -2.1
15.0 11.4 8.7 22.4 19.5 26.5 9.4




82.4 75.7 39.65.7 -7.5
74.8 38.984.9 3.5 -8.5
0.0-0.4 0.1 0.2 0.1 -0.5 0.3
-0.9-1.20.5 -0.6 -0.9 -0.4 -0.8
Table 5. Cyclosporine study - Caucasian sample, 1996 (1-18) and 2001 (29-38) - 
cumulative.
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CYCLOSPORINE STUDY - HISPANIC SAMPLE 






AngleSNA SNB ANB Go-Gn-SN
19 85.1 76.4 8.6 42.0 20.5 127.8 -8.4
20 89.0 80.4 8.6 33.4 15.5 136.5 -8.6
21 82.2 77.0 5.2 39.6 12.8 125.2
127.2
-3.9
22 84.7 80.5 4.2 36.4 10.7 -5.5
23 80.8 77.3 3.5 36.5 8.2 133.1 -3.5
24 79.2 76.2 3.1 36.4 8.0 129.5
145.8
-3.1
25 82.0 79.6 2.4 40.8 6.4 -1.6
26 84.2 80.4 37.43.8 8.4 130.3 -4.5
27 85.7 79.9 37.85.8 13.5 129.8 -6.0
28 80.5 3.876.7 36.4 132.59.7 -4.4









40 83.1 71.4 11.7 47.4 26.0
85.941 77.9 8.0 38.5 17.5
42 84.1 74.7 9.5 47.9 23.0
88.143 77.9 10.2 46.4 21.0
44 79.6 72.3 7.2 43.4 16.5 -8.0
45 79.3 74.7 4.6 41.1 12.0 -6.0














81.9 76.1 5.8 40.4 12.1 133.1 -7.1
3.2 3.4 2.4 5.7 5.6 7.1 2.6
10.4 11.3 6.0 32.3 31.5 50.2 6.5
0.6 0.6 0.5 1.1 1.1 1.3 0.5
4.43.9 42.4 14.1 46.4 5.3 -36.2
117.0 -11.573.4 70.4 28.51.4 2.5
88.4 81.8 10.1 50.9 22.0 143.5 -2.1
15.0 22.411.4 8.7 19.5 26.5 9.4
2292.0 2130.9 161.2 1131.0 338.5 3726.7 -197.9
134.0 -7.5
138.4 -8.5
82.4 75.7 5.7 39.6 11.8
84.9 74.8 3.5 38.9 8.0
-0.4 0.1 0.2 0.0 0.1 -0.5 0.3
0.5 -1.2 -0.9 -0.6 -0.9 -0.4 -0.8







Age Bone Age 
Yr-Mo
SD
Subject Sex/Race Yr-Mo Mo
M/C3 8-9 7-0 11.0 D
M/C4 9-11 10-0 11.4 N
F/C6 11-5 10-0 13.0 D
M/C8 11-7 11-6 10.4 N
M/C14 13-1 13-0 11.2 N
F/C15 11-0 11-0 12.3 N
F/C16 12-5 12-6 14.3 N
F/C17 14-11 15-0 11.2 N
F/H19 9-6 11-0 10.1 A
M/H21 10-10 11-0 10.5 N
F/H24 10-1 10-0 10.8 N
M/C29 6-0 6-0 9.3 N
M/C30 6-3 6-0 9.5 N
M/C31 6-3 4-6 9.5 D
F/C32 6-3 6-0 8.8 N
F/C33 5-7 5-0 8.9 N
M/C34 12-6 12-6 10.8 N
M/C35 7-8 5-6 10.6 D
F/C36 11-10 12-0 13.8 N
M/C37 9-10 8-6 11.4 D
M/C38 6-4 5-6 10.1 N
M/H39 15-1 15-0 14.3 N
M/H40 7-10 6-6 10.7 D
M/H41 7-3 6-6 10.3 N
M/H42 7-6 7-0 10.5 N
M/H43 5-8 3-6 9.2 D
44 M/H 12-4 11-6 10.6 N
M/H45 6-1 5-6 9.3 N
F/H46 11-6 12-6 10.3 A
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MMMFFMfj! FMMMMMM MMMF 
CCCCCCC CCCHHHH HHHH
Individual Transplant Patients - New Subjects
Legend
C = Caucasian transplant patients 
H = Hispanic transplant patients 
M = male; F = female
Dashed line = coincidence of chronologic age and bone age 
• = less than 1 SD
+ = more than 1 SD but less than 2 SD 
■ = greater than 2 SD
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MMFMMFFFFMF 
CCCCCCCCHHH
Individual Transplant Patients - Longitudinal Subjects (1996 and 2001) 
Legend
C = Caucasian transplant patients 
H = Hispanic transplant patients 
M = male; F = female
Dashed line = coincidence of chronologic age and bone age 
• = less than 1 SD, 1996 
+ = more than 1 SD but less than 2 SD, 1996 
®= less than 1 SD, 2001 
©= more than 1 SD but less than 2 SD, 2001 
Note: Subject No. 15-1996 and 2001 readings coincident 
Subject No. 17 - No reading for 1996
Figure 9. Plotting the difference between the subject bone age and chronologic age. 
Longitudinal subjects.
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age of greater than 2 standard deviations. Figure 9 plots the difference between each
longitudinal subjects bone age and chronologic age (except for subject #17 in 1996) for
both the 1996 and 2001 studies. This scatter plot shows that 9/10 subjects were within
one standard deviation and that 1/10 subjects (#6) were within two standard deviations in
1996. No subject showed a decreased bone age of greater than two standard deviations
in 1996. This scatter plot also shows that 8/11 subjects were within one standard
deviation and that 3/11 subjects (#3, #6 delayed, #19 advanced) were within 2 standard
deviations in 2001. Subject #3 showed a decrease of one full standard deviation in bone
age from 1996 to 2001. Subject #19 showed the opposite with an increase of one frill
standard deviation in bone age from 1996 to 2001. Subject #6 displayed decreased bone
age (more than one standard deviation but less than two standard deviations) in 1996 and
continued that trend in 2001. The remaining 7/10 subjects whose bone age was within
one standard deviation of their chronological age continued that pattern with either minor 
increases, decreases or no change exhibited.
Height, weight and head circumference data for the 1996 sample was recorded in 
Figure 10 by plotting against standard NCHS growth curve percentiles in which the 50th 
percentile represents normative growth. For head circumference data there were 7/28 
above the 50th percentile, but there were 21/28 at or below the 50th percentile. For weight 
data there were 7/28 above the 50th percentile with 21/28 at or below the 50th percentile. 
For height data there were 4/28 above the 50th percentile with 22/28 at or below the 50th 
percentile. Figure 11 records the same height, weight and head circumference data for
the 2001 sample first time participants. For head circumference data there were 6/17 (no 
head circumference reading for subject #33 was available) above the 50th percentile with
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11/17 below the 50th percentile. For weight data there were 4/18 above the 50th percentile 
with 14/18 below the 50th percentile. For height data there were 3/18 above the 50th 
percentile with 15/18 below the 50th percentile. Height and weight data (head 
circumference unchanged) for the 2001 longitudinal (returning subjects) sample was 
recorded in Figure 12. By plotting 2001 data with dashed lines or circled dots and 1996 
data with solid lines and dots, one can easily compare readings to determine if any “catch
up” growth has occurred in the last five years. For weight data there were 3/11 above the 
50th percentile with 8/11 at or below the 50th percentile. The weight percentile remained
constant for 5/11 subjects (#4, #8, #16, #19, #24), improved for 3/11 subjects (#3, #14,
#17) and declined for 3/11 subjects (#6, #15, #21). For height data, 4/11 were at or
above the 50th percentile with 8/11 at or below the 50th percentile. The height percentile
ranking remained constant for 3/11 subjects (#3, #8, #16), improved for 5/11 subjects
(#4, #15, #17, #19, #21) and declined for 3/11 subjects (#6, #14, #24).
Subjective clinical, photographic, and panoramic radiographic analysis was also
evaluated (Table 8). The photographic records revealed that 14/29 subjects exhibited
abnormally excessive facial hair growth or hypertrichosis. Also it was observed
photographically that two individuals (#39, #44) did exhibit facial appearance 
abnormalities similar to those documented by Reznik.1 Clinical examination revealed
24/29 subjects exhibited gingival hyperplasia with 10 classified as mild (5-25% of
clinical crown obscured), seven as moderate (25-50% of clinical crown obscured), and
seven as severe (50-100% of clinical crown obscured), possibly requiring future
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1-18 = Caucasian transplant patients 
19-28 = Hispanic transplant patients 
M = male; F = female 
50th percentile = normative growth
A point represents a measurement which fell on a specific percentile line 
A vertical bar represents a point which fell between two percentile lines 
*National Center for Health Statistics (1979)
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29-38 = Caucasian transplant patients 
39-46 = Hispanic transplant patients 
M = male; F = female 
50th percentile = normative growth
A point represents a measurement which fell on a specific percentile line 
A vertical bar represents a point which fell between two percentile lines 
‘National Center for Health Statistics (1979)
No head circumference data for subject #33
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Legend
3-17 = Caucasian transplant patients 
19-24 = Hispanic transplant patients 
M = male; F = female 
50th percentile = normative growth
A point represents a measurement which fell on a specific percentile line - 1996 
A vertical bar represents a point which fell between two percentile lines - 1996 
A circled point represents a measurement which fell on a specific percentile line - 2001 
A dashed vertical bar represents a point which fell between two percentile lines - 2001 
'National Center for Health Statistics (1979)
No head circumference data for subject #33


















































































Table 8. Subjective clinical, photographic and panoramic radiographic analysis. (N=29)
Upon radiographic analysis there seemed to be an unusually high incidence of
congenitally missing permanent teeth and a slightly elevated incidence of ankylosed
primary molars. Of the new study participants (N=T8), five subjects (28%) exhibited
radiographic evidence of congenitally missing either maxillary second premolars.
mandibular first or second premolars, maxillary lateral incisors or maxillary or
36
mandibular third molars (age 11 years-5 months or older) or a combination. One subject
(#34) exhibited radiographic evidence of missing nine permanent teeth (5 premolars and
4 third molars) and another subject (#8) exhibited radiographic evidence of missing seven
permanent teeth (1 lateral incisor, 2 premolars and 4 third molars). Two (11%) of the
individuals showed radiographic and photographic evidence of ankylosis of primary
molars.
The 1996 and 2001 tracings of the lateral cephalographs of the longitudinal
subjects (Figure 13: subjects #3, #4, #6, #8, #14, #15, #16, #17, #19, #21, and #24) were
superimposed via the American Board of Orthodontics craniofacial growth format with a
“best fit” with the anterior cranial base due to the fact that the anatomical landmark sella 
changes with growth.30 Those superimpositions displayed a relatively normal downward 
and forward growth pattern of the maxilla and mandible for 9/11 subjects. Two of the
subjects exhibited a downward and somewhat backward (clockwise rotation) or 
retrognathic pattern of mandibular growth as suggested by Reznik.
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Figure 15. Cephalometric superimpositions of longitudinal subjects - #6.
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Figure 17. Cephalometric superimpositions of longitudinal subjects - #14.
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Figure 20, Cephalometric superimpositions of longitudinal subjects - #17.
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Figure 21, Cephalometric superimpositions of longitudinal subjects - #19.
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Figure 22. Cephalometric superimpositions of longitudinal subjects - #21
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Figure 23. Cephalometric superimpositions of longitudinal subjects - #24.
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IV. DISCUSSION
Abnormal or dysmorphic craniofacial growth and its relation to the therapeutic
drug regimen, cyclosporine, was the primary interest of this study. The deletrious side
6,16,17 Reznick et al1,2effects of cyclosporine have been well documented in the literature.
implicated cyclosporine as adversely affecting craniofacial growth in renal
transplantation recipients. In order to better understand the long-term effects of
cyclopsorine on growth, we have examined the craniofacial and axial skeletal
development of an ever expanding cumulative and longitudinal database of infant heart
transplant recipients and compared them to normative growth data.
In general, chronic illness, congenital influences, trauma, developmental defects.
environmental factors and teratogens are some of the factors that have been implicated in
the disturbance of normal skeletal and craniofacial growth. It has also been recognized
that there are at least four major components to the complex phenomenon of craniofacial
growth and development. These include the cranial base synchondrosis and the calvarial
sutures being influenced by the CNS and other soft tissue growth, the nasal septal
cartilage, the remodeling growth of the maxilla and mandible and the cartilagenous 
growth at the temporomandibular condyle.31 Certain etiologic factors that affect any or
all of these components may cause morphometric changes in craniofacial growth 
patterns.32
One purpose of this investigation was to determine if Reznik’s findings that the
cyclosporine group had a larger GoGn-SN resulting in a steep mandibular plane angle 
and mandibular retrognathia was evident in our infant heart transplant group.2 When
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examining the cephalometric paramters most indicative of mandibular retrognathia (SNB,
ANB, GoGn-SN and Gonial Angle) for the longitudinal subjects, our data revealed only
three subjects (#3, #4, #15) with growth trends pointing towards retrognathia. Subject #3
was the only subject (out of 11) to display an increase in Gonial Angle, however, this was
not significant in light of the fact that he progressed from prognathic (in 1996) to normal
(in 2001) for SNB and was normal in all the other mandibular parameters. Subject #4
was (in 1996) and remains (in 2001) mildly retrognathic but did not exhibit steep
mandibular plane angle. Subject #15 displayed the most consistent trend toward
retrognathia by proceeding from prognathic (in 1996) to retrognathic (in 2001) for SNB
and displaying an increase in values for ANB and GoGn-SN (in 2001). Inconsistent with
the retrognathic trend was, however, a reduction in the Gonial Angle (in 2001). The
subject was also within one standard deviation of the normative standards for 4/7
cephalometric parameters and between the first and second standard deviation for the
remaining three.
Although the group was small, it was interesting to note that all three Hispanic
longitudinal subjects displayed a mandibular growth pattern that tended toward
prognathia rather than retrognathia.
Statistical analysis of the 1996 data and the 2001 data compared to the normative
data for the Caucasian sample using a one-sample t-test (at a significance level a=.05)
revealed SNB 2001 significantly greater than SNB 1996 (p=.047) and GnGn-SN 1996
significantly greater than GoGn-SN 2001 (p=.034). The same statistical analysis of the
means applied to the longitudinal 1996 and 2001 Hispanic sample means revealed no
significant difference due to the small sample size (N=3). Although the previously
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mentioned cephalometric parameters were found to be statistically significant, the mean
difference (less than 2 degrees) was not considered clinically significant.
What was considered clinically significant was the fact that 9/11 longitudinal
subjects exhibited a downward and forward (counter-clockwise rotation) growth pattern
of the maxilla and mandible when evaluated by cephalometric superimposition of the
1996 and 2001 lateral cephalographic tracings. This important finding was strong
longitudinal evidence to support a growth pattern that can be considered normal and
hopefully will continue in the subjects through skeletal maturity. This data was contrary 
to the data reported by Reznik and strengthens the premise that long-term cyclosporine
immunomodulation does not seem to cause a steep mandibular plane angle with
mandibular retrognathia, at least over the time period and with the subjects evaluated. No
definitive conclusions could be made concerning the etiology for the two subjects who
exhibited a downward and backward growth pattern.
Our cephalometric data revealed that 86% (N=25) showed minor deviation from
mean normative values. Most measures for each subject were within 1 or 2 standard
deviations.
Four new subjects (#31, #40, #42, and #43) exhibited cephalometric
measurements indicative of individuals with a vertical growth pattern and apparent
mandibular retrognathia as evidenced by an increased GoGn-SN angle, ANB angle and
Gonial Angle. At the time of writing it was discovered that subject #31 was afflicted
with cerebral palsy and should have been disqualified from the study due to the presence
of confounding variables. This would also explain why this subject had decreased bone 
age and was in the 0-5th percentile rankings for head circumference, weight and height.
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Subject #43 has undergone a second heart transplantation at age five due to complications
after his first graft and has had six rejection episodes requiring treatment with multiple
courses of solumedrol and prednisone rescue therapy. He is still classified as “failing to 
thrive” by heart institute prediatricians due to lack of appetite and poor growth progress. 
This medical evidence could explain his decreased bone age and 0-5th percentile ranking
in head circumference, height and weight. Subject #42 also had six rejection episodes
requiring extensive exposure to glucocorticoid therapy but did not exhibit decreased bone
age or severly suppressed statural development. No definitive conclusion could be drawn
concerning the specific etiology of the vertical growth pattern for subject #40 other than
normal variations within a given sample. The fact that the majority of the individual
subjects in each group for both the 1996 study and the 2001 study were within two
standard deviations of the normative standards would suggest a relatively normal pattern
of facial growth for these groups and would seem inconclusive in relation to the
cyclosporine.
Only two additional subjects (#3, #35) exhibited a decreased bone age upon
carpal index analysis. Subject #3 was worthy of mention because his bone age and
chronologic are were coincident for the 1996 study. The subject has undergone a second
transplantation shortly after the 1996 study and now exhibits a bone age that is 21 months
less than his chronologic age. He has, however, maintained his height percentile ranking
constant and has moved up to the next weight percentile ranking. There is no significant
medical evidence to explain the decreased bone age of subject #35. The facial and
skeletal presentation of this subject appeared within normal limits. Overall, this would
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support the idea of a relatively normal pattern of axial skeletal development for this
sample.
Longitudinal height and weight data revealed a substantial range in growth
percentiles for the group. Mean height and weight percentiles did suggest a tendency for
suppressed or delayed statural development. Mean head circumference percentiles at age
three years were similar to the height and weight data obtained. The role of chronic
illness, individual genetic variability, and teratogenic influence on general growth and
development cannot be overlooked in evaluating this sample and requires further study.
Clinically, only two individuals (#39, #44) exhibited a facial appearance similar to those
reported by Reznik. Neither of these subjects showed any significant skeletal
abnormalities, and no single variable could be implicated in the dysmorphic presentation
seen. Subject #39 had eight rejection episodes requiring the long-term use of prednisone.
This could be considered as a primary etiologic factor in his “cushinoid-like” facial
appearance. Subject #44 has not had any rejection episodes requiring oral prednisone
therapy.
Of the new study participants (N=T8), five subjects (28%) were missing one or
more permanent teeth and two subjects (11%) showed radiographic and photographic
evidence of ankylosis of primary molars. The radiographic presence of permanent third
molars could be evaluated in the subjects that were at least age 11 years-6 months or 
older.33 When evaluating the entire 2001 sample (new and longitudinal subjects), the
most commonly found missing teeth were maxillary or mandibular permanent third
molars (20) followed by maxillary or mandibular permanent second premolars (9),
maxillary permanent lateral incisors (3) and mandibular permanent first premolars (1).
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This permanent tooth agenesis is a significant finding due to the fact that fewer than 4%
of the general population have one or more teeth congenitally missing. In addition,
although primary molar ankylosis is prevalent among approximately 8% of the general 
population, it was observed in 11% of the new study participants.34 No definitive
conclusions could be made concerning the primary etiologic factor for these interesting
findings.
Once again, our data seems to support the premise that any untoward craniofacial
growth and/or skeletal development exhibited by the Loma Linda University infant heart
transplant population cannot be directly correlated to the cyclosporine
immunomodulatory regimen they must follow in order to survive. It would seem prudent
and reasonable to question whether the few craniofacial irregularities noted were truly
dysmorphic changes caused by cyclosporine immunomodulation, or the result of multiple
hereditary, developmental and environmental factors exerting their influence. If one
could compare this sample to a randomly matched sample of non-medically
compromised children within the general population, one might find similar diversity as
viewed in this longitudinal study.
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V. CONCLUSION
In conclusion, the morphometric analysis of 29 cardiac transplant children treated
with long-term cyclosporine immunosuppression showed a relatively normal pattern of
craniofacial growth and development for the majority of the sample studied. As the
database increased in number (in 2001) from 28 to 46 subjects, it was noted that the
sample means for the cephalometric parameters evaluated became even more closely
matched (than in 1996) with the normative values for those parameters. Also, the vector
of craniofacial growth for the majority of the longitudinal subjects appeared to be
downward and forward as observed in the initial 1996 pilot study. Our data did not 
concur with the findings from previous studies.1,2. It would be difficult at this time to
implicate cyclosporine immunomodulation as the sole factor responsible for adversely
affecting craniofacial growth and development when one takes into account the unlimited
variability of genetic factors as well as individual response to chronic illness and
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